Effect of chlorogenic acid on LPS-induced proinflammatory signaling in hepatic stellate cells

Inflammation Research

Volumn 62, Issue 6, 2013, Pages 581-587

  Shi, Haitao ^a   Dong, Lei ^a   Dang, Xiaoyan ^a   Liu, Yaping ^a   Jiang, Jiong ^a   Wang, Yan ^a   Lu, Xiaolan ^a   Guo, Xiaoyan ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Chlorogenic acid; Inflammation; LPS

Indexed keywords

ACETYLCYSTEINE; CHLOROGENIC ACID; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; PYRROLIDINE DITHIOCARBAMATE; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL CULTURE; CELL IMMORTALIZATION; CELL NUCLEUS; CELL STIMULATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IN VITRO STUDY; INHIBITION KINETICS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STELLATE CELL; SUPERNATANT; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CHEMOKINE CCL2; CHLOROGENIC ACID; HEPATIC STELLATE CELLS; I-KAPPA B PROTEINS; INFLAMMATION; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; NF-KAPPA B; RATS; REACTIVE OXYGEN SPECIES; TOLL-LIKE RECEPTOR 4;

EID: 84878223917     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-013-0610-7     Document Type: Article

References (41)

1. Bataller R, Brenner DA. Liver fibrosis. J Clin Investig. 2005;115:209-18.
2. Friedman SL. Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol and Hepatol. 2010;7:425-36.
3. Fallowfield JA. Therapeutic targets in liver fibrosis. Am J Physiol-Gastrointest Liver Physiol. 2011;300:G709-15.
4. Kawada N. Evolution of hepatic fibrosis research. Hepatol Res. 2011;41:199-208.
5. Saile B, Ramadori G. Inflammation, damage repair and liver fibrosis - role of cytokines and different cell types. Z Gastroent. 2007;45:77-86.
6. Pinzani M, Macias-Barragan J. Update on the pathophysiology of liver fibrosis. Expert Rev Gastroenterol Hepatol. 2010;4:459-72.
7. O'Neill LA. Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases. Curr Opin Pharmacol. 2003;3:396-403.
8. Zhu JK, Mohan C. Toll-like receptor signaling pathways-therapeutic opportunities. Mediat Inflamm. 2010. Art ID 781235.
9. Aoyama T, Paik YH, Seki E. Toll-like receptor signaling and liver fibrosis. Gastroenterol Res Pract. 2010. Art ID 192543.
10. Lin RS, Lee FY, Lee SD, Tsai YT, Lin HC, Lu RH, et al. Endotoxemia in patients with chronic liver-diseases - relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. J Hepatol. 1995;22:165-72.
11. Parlesak A, Schafer C, Schutz T, Bode JC, Bode C. Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J Hepatol. 2000;32:742-7.
12. Choi Y, Jeon WK, Hwang SJ, Kim BI, Sohn CI, Park DI, et al. The Role of the Gut Barrier Function in the Pathophysiology of Viral Liver Cirrhosis. Hepato-Gastroenterol. 2011;58:1244-7.
13. Seki E, Brenner DA. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology. 2008;48:322-35.
14. Brun P, Castagliuolo I, Pinzani M, Palu G, Martines D. Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells. Am J Physiol-Gastroint Liver Physiol. 2005;289:G571-8.
15. Paik YH, Schwabe RF, Bataller R, Russo MP, Jobin C, Brenner DA. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology. 2003;37:1043-55.
16. Thirunavukkarasu C, Watkins SC, Gandhi CR. Mechanisms of endotoxin-induced NO, IL-6, and TNF-alpha production in activated rat hepatic stellate cells: role of p38 MAPK. Hepatol. 2006;44:389-98.
17. Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA, et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med. 2007;13:1324-32.
18. Feng RT, Lu YJ, Bowman LL, Qian Y, Castranova V, Ding M. Inhibition of activator protein-1, NF-kappa B, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. J Biol Chem. 2005;280:27888-95.
19. Zhang X, Huang H, Yang TT, Ye Y, Shan JH, Yin ZM, et al. Chlorogenic acid protects mice against lipopolysaccharide-induced acute lung injury. Inj Int J Care Inj. 2010;41:746-52.
20. Kono Y, Kobayashi K, Tagawa S, Adachi K, Ueda A, Sawa Y, et al. Antioxidant activity of polyphenolics in diets Rate constants of reactions of chlorogenic acid and caffeic acid with reactive species of oxygen and nitrogen. Biochim Biophys Acta. 1997;1335:335-42.
21. Shi HY, Dong L, Bai YH, Zhao JH, Zhang Y, Zhang L. Chlorogenic acid against carbon tetrachloride-induced liver fibrosis in rats. Eur J Pharmacol. 2009;623:119-24.
22. Xu YX, Chen JW, Yu XA, Tao WW, Jiang FR, Yin ZM, et al. Protective effects of chlorogenic acid on acute hepatotoxicity induced by lipopolysaccharide in mice. Inflamm Res. 2010;59:871-7.
23. Shan JH, Fu J, Zhao ZH, Kong XQ, Huang H, Luo L, et al. Chlorogenic acid inhibits lipopolysaccharide-induced cyclooxygenase-2 expression in RAW264.7 cells through suppressing NF-kappa B and JNK/AP-1 activation. Int Immunopharmacol. 2009;9:1042-8.
24. Wang BB, Cheng JY, Gao HH, Zhang Y, Chen ZN, Bian HJ. Hepatic stellate cells in inflammation-fibrosis-carcinoma axis. Anat Rec. 2010;293:1492-6.
25. Vogel S, Piantedosi R, Frank J, Lalazar A, Rockey DC, Friedman SL, et al. An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. J Lipid Res. 2000;41:882-93.
26. Lebel CP, Ischiropoulos H, Bondy SC. Evaluation of the probe 2′, 7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol. 1992;5:227-31.
27. Choi HK, Pokharel YR, Lim SC, Han HK, Ryu CS, Kim SK, et al. Inhibition of liver fibrosis by solubilized coenzyme Q10: Role of Nrf2 activation in inhibiting transforming growth factor-beta 1 expression. Toxicol Appl Pharmacol. 2009;240:377-84.
28. Gill R, Tsung A, Billiar T. Linking oxidative stress to inflammation: Toll-like receptors. Free Radical Biol Med. 2010;48:1121-32.
29. Wu J, Meng ZJ, Jiang M, Zhang EJ, Trippler M, Broering R, et al. Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific. Immunology. 2010;129:363-74.
30. Lu YC, Yeh WC, Ohashi PS. LPS/TLR4 signal transduction pathway. Cytokine. 2008;42:145-51.
31. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature. 1997;388:548-54.
32. Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M. The I kappa B kinase complex (IKK) contains two kinase subunits, IKK alpha and IKK beta, necessary for I kappa B phosphorylation and NF-kappa B activation. Cell. 1997;91:243-52.
33. Marra F, DeFranco R, Grappone C, Milani S, Pastacaldi S, Pinzani M, et al. Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration. Am J Pathol. 1998;152:423-30.
34. Wasmuth HE, Tacke F, Trautwein C. Chemokines in liver inflammation and fibrosis. Semin Liver Dis. 2010;30:215-25.
35. Seki E, De Minicis S, Inokuchi S, Taura K, Miyai K, Van Rooijen N, et al. CCR2 Promotes Hepatic Fibrosis in Mice. Hepatology. 2009;50:185-97.
36. Marra F, Romanelli RG, Giannini C, Failli P, Pastacaldi S, Arrighi MC, et al. Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. Hepatology. 1999;29:140-8.
37. Tsuruta S, Nakamuta M, Enjoji M, Kotoh K, Hiasa K, Egashira K, et al. Anti-monocyte chemoattractant protein-1 gene therapy prevents dimethylnitrosamine-induced hepatic fibrosis in rats. Int J Mol Med. 2004;14:837-42.
38. Kayano K, Okita K. Does IL-6 regulate liver fibrosis/cirrhosis directly and indirectly? J Gastroenterol. 2000;35:250-1.
39. Choi I, Kang HS, Yang Y, Pyun KH. IL-6 induces hepatic inflammation and collagen-synthesis in vivo. Clin Exp Immunol. 1994;95:530-5.
40. Asehnoune K, Strassheim D, Mitra S, Kim JY, Abraham E. Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappaB. J Immunol. 2004;172:2522-9.
41. Park HS, Jung HY, Park EY, Kim J, Lee WJ, Bae YS. Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappaB. J Immunol. 2004;173:3589-93.